| On Tuesday 10 November: |
| 13:30 - 13:40 |
Introduction
|
| 13:40 - 14:10 |
Context and clinical aspects of malaria: why still a need for new malaria medications? (Prof Jean-Pierre Van Geertruyden, MD, PhD, Full Professor Global Health Institute University of Antwerp)
|
| 14:10 - 14:15 |
Q&A session
|
| 14:15 - 14:45 |
The value of VIS in early phase antimalarial drug development (Dr Farouk Chughlay, MD MMed FCCP Dip HIV Medical Director: Experimental Medicine & Clinical Pharmacology Medicines for Malaria Venture)
|
| 14:45 - 14:50 |
Q&A session
|
| 14:50 - 15:20 |
SGS Phase I unit experience with malaria challenge trials: a case pivotal study (Dr Pieter-Jan Berghmans, MD, FBCPM Investigator SGS – CPU)
|
| 15:20 - 15:25 |
Q&A session
|
| 15:25 - 15:30 |
Closing remarks
|
